Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%) Natco Pharma board to consider unaudited financial results
Date: 31-01-2013Natco Pharma has informed that a meeting of the board of directors of the company will be held on February 13, 2013, to consider the unaudited financial Results for the quarter ended December 31, 2012, to consider interim dividend, if any, for the financial year 2012-13 and related matters etc.
The above information is a part of company’s filings submitted to BSE.